ISM1 and colorectal carcinoma: The correlations between ISM1 and markers of suppressive immune cells (M2 macrophages, Tregs, T cell exhaustion) and the overexpression of ISM1 detected in PD1-resistant patients further confirmed our speculation that ISM1 upregulation is potentially involved in immunotherapy resistance via immune-related pathways in CRC.